Literature DB >> 34807341

Update on management of craniopharyngiomas.

Fraser Henderson1, Theodore H Schwartz2.   

Abstract

PURPOSE/
INTRODUCTION: Craniopharyngiomas are locally-aggressive tumors arising along the hypothalamic-pituitary axis. Treatment is nuanced as a result of their proximity and adherence to vital neurovascular structures and responsiveness to surgery, radiation and, in some cases, chemotherapy.
METHODS: We reviewed the literature discussing the current state of knowledge regarding craniopharyngioma biology and therapy.
RESULTS: Recent advances in endoscopic endonasal surgery (EEA) have made surgery a safer and more effective option. While cure may be achieved with gross total resection (GTR), when felt to be too risky, a subtotal resection followed by radiation is often a more prudent strategy, particularly in children with hypothalamic invasion. Data on long-term outcome are mostly derived from older studies in which a craniotomy, rather than EEA, was performed. Long-term EEA outcome studies are lacking. Enhanced knowledge of the biological basis of papillary CPs has led to novel medical treatments for BRAFv600E variants that appear to be effective.
CONCLUSION: Endoscopic technology has improved surgical results for craniopharyngiomas and expanded the indications for the transsphenoidal approach. The goal of CP surgery goal is maximal safe resection to achieve cure, but subtotal resection and radiation may be equally effective. Early diagnosis of specific variants will facilitate enrollment in promising medical trials.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Craniopharyngioma; Endoscopic; Surgery; Treatment

Mesh:

Year:  2021        PMID: 34807341     DOI: 10.1007/s11060-021-03906-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  70 in total

1.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.

Authors:  Anthe S Sterkenburg; Anika Hoffmann; Ursel Gebhardt; Monika Warmuth-Metz; Anna M M Daubenbüchel; Hermann L Müller
Journal:  Neuro Oncol       Date:  2015-04-02       Impact factor: 12.300

2.  Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.

Authors:  Brad E Zacharia; Samuel S Bruce; Hannah Goldstein; Hani R Malone; Alfred I Neugut; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2012-06-26       Impact factor: 12.300

3.  Transsphenoidal microsurgery in the management of craniopharyngioma.

Authors:  E R Laws
Journal:  J Neurosurg       Date:  1980-05       Impact factor: 5.115

4.  The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients.

Authors:  Luigi Maria Cavallo; Giorgio Frank; Paolo Cappabianca; Domenico Solari; Diego Mazzatenta; Alessandro Villa; Matteo Zoli; Alfonso Iodice D'Enza; Felice Esposito; Ernesto Pasquini
Journal:  J Neurosurg       Date:  2014-05-02       Impact factor: 5.115

5.  Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors.

Authors:  Ruth Prieto; José María Pascual; Maria Rosdolsky; Inés Castro-Dufourny; Rodrigo Carrasco; Sewan Strauss; Laura Barrios
Journal:  Neurosurg Focus       Date:  2016-12       Impact factor: 4.047

Review 6.  Craniopharyngioma treatment: an updated summary of important clinicopathological concepts.

Authors:  Ruth Prieto; Maria Rosdolsky; Verena Hofecker; Laura Barrios; José M Pascual
Journal:  Expert Rev Endocrinol Metab       Date:  2020-07

7.  Jakob Erdheim (1874-1937): father of hypophyseal-duct tumors (craniopharyngiomas).

Authors:  José M Pascual; María Rosdolsky; Ruth Prieto; Sewan Strauβ; Eduard Winter; Walter Ulrich
Journal:  Virchows Arch       Date:  2015-06-19       Impact factor: 4.064

8.  Prognostic factors for long-term outcomes of microvascular decompression in the treatment of glossopharyngeal neuralgia: a retrospective analysis of 97 patients.

Authors:  Wentao Zheng; Peng Zhao; Haidong Song; Bo Liu; Jingru Zhou; Cungang Fan; Dongliang Wang; Ruen Liu
Journal:  J Neurosurg       Date:  2021-12-17       Impact factor: 5.115

9.  The descriptive epidemiology of craniopharyngioma.

Authors:  G R Bunin; T S Surawicz; P A Witman; S Preston-Martin; F Davis; J M Bruner
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

10.  Adult Craniopharyngioma: Case Series, Systematic Review, and Meta-Analysis.

Authors:  Charlotte Dandurand; Amir Ali Sepehry; Mohammad Hossein Asadi Lari; Ryojo Akagami; Peter Gooderham
Journal:  Neurosurgery       Date:  2018-10-01       Impact factor: 4.654

View more
  2 in total

1.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

2.  Craniopharyngioma and the Third Ventricle: This Inescapable Topographical Relationship.

Authors:  José María Pascual; Ruth Prieto
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.